These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6849451)

  • 1. Questioning DST normalization as a guide to tricyclic discontinuation.
    Lieberman JA; Kane JM
    Am J Psychiatry; 1983 Feb; 140(2):263-4. PubMed ID: 6849451
    [No Abstract]   [Full Text] [Related]  

  • 2. Life events and the dexamethasone suppression test in affective illness.
    Mendlewicz J; Charon F; Linkowski P
    J Affect Disord; 1986; 10(3):203-6. PubMed ID: 2943773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test as an indication of depression in patients with mental retardation.
    Mattes JA; Amsell L
    Am J Ment Retard; 1993 Nov; 98(3):354-9. PubMed ID: 7904820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overnight dexamethasone suppression test: clinical and theoretical review.
    Gwirtsman H; Gerner RH; Sternbach H
    J Clin Psychiatry; 1982 Aug; 43(8):321-7. PubMed ID: 7047505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tricyclic antidepressants on the dexamethasone suppression test.
    Amsterdam JD; Winokur A; Caroff S
    Am J Psychiatry; 1981 Sep; 138(9):1245-6. PubMed ID: 7270735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some conceptual aspects of laboratory tests in depression.
    Davis JM; Dysken MW; Matuzas WM; Nasr SJ
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):21-6. PubMed ID: 6853456
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychotropic drug withdrawal and the dexamethasone suppression test.
    Kraus RP; Hux M; Grof P
    Am J Psychiatry; 1987 Jan; 144(1):82-5. PubMed ID: 3799844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in psychopharmacology of depression.
    Johnson GF
    Aust N Z J Psychiatry; 1981 Sep; 15(3):223-7. PubMed ID: 6174112
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroendocrine dysfunction and response to tricyclic antidepressants.
    Kirstein L
    J Clin Psychiatry; 1984 Sep; 45(9):385-6. PubMed ID: 6432772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricyclic-resistant depression.
    Berkowitz HL
    J Clin Psychiatry; 1986 Jul; 47(7):393. PubMed ID: 3722140
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic drug monitoring with tricyclic antidepressants: a response.
    Preskorn SH
    J Clin Psychopharmacol; 1994 Aug; 14(4):277-8. PubMed ID: 7962685
    [No Abstract]   [Full Text] [Related]  

  • 12. Choice of antidepressant based on the dexamethasone suppression test.
    Fraser AR
    Am J Psychiatry; 1983 Jun; 140(6):786-7. PubMed ID: 6846641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DST results in nonpsychotic depressed outpatients.
    Khan A; Johnson F; Avery DH; Cohen S; Scherzo B; Dunner DL
    Am J Psychiatry; 1988 Sep; 145(9):1153-6. PubMed ID: 3046385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short gut syndrome, tricyclic antidepressants, and prolonged QT interval syndromes.
    DiMartini A
    Psychosomatics; 1997; 38(4):401-2. PubMed ID: 9217415
    [No Abstract]   [Full Text] [Related]  

  • 16. The dexamethasone suppression test and response to methylphenidate in depression.
    Sternbach H; Gwirtsman H; Gerner RH
    Am J Psychiatry; 1981 Dec; 138(12):1629-31. PubMed ID: 7304800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test and treatment response.
    Gitlin MJ; Gwirtsman H; Fairbanks L; Sternbach HA; Cedars PI; Gerner RH
    J Clin Psychiatry; 1984 Sep; 45(9):387-9. PubMed ID: 6469923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA; Greden JF; Tarika J; Carroll BJ
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of serial neuroendocrine challenge studies in the management of depressive disorder.
    Targum SD
    Biol Psychiatry; 1983 Jan; 18(1):3-19. PubMed ID: 6403062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor.
    Brown WA; Arato M; Shrivastava R
    Am J Psychiatry; 1986 Jan; 143(1):88-90. PubMed ID: 3079969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.